These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 734542)

  • 1. [Breast cancer].
    S Afr Med J; 1978 Sep; 54(10):379. PubMed ID: 734542
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormone receptors in the management of breast cancer.
    Osborne CK
    Tex Med; 1984 Nov; 80(11):30-2. PubMed ID: 6515569
    [No Abstract]   [Full Text] [Related]  

  • 3. New approaches for triple-negative breast cancer.
    Oncology (Williston Park); 2012 Oct; 26(10):916, 931, 935. PubMed ID: 23175999
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hormonreceptors in the therapy concept of breast cancer (author's transl)].
    Jonat W; Maass H
    Arch Geschwulstforsch; 1981; 51(7):637-41. PubMed ID: 7337546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dynamics of estrogen receptor status in breast cancer: re-shaping the paradigm.
    Lopez-Tarruella S; Schiff R
    Clin Cancer Res; 2007 Dec; 13(23):6921-5. PubMed ID: 18056165
    [No Abstract]   [Full Text] [Related]  

  • 6. Targeting Notch signaling cross-talk with estrogen receptor and ErbB-2 in breast cancer.
    Rizzo P; Osipo C; Pannuti A; Golde T; Osborne B; Miele L
    Adv Enzyme Regul; 2009; 49(1):134-41. PubMed ID: 19344631
    [No Abstract]   [Full Text] [Related]  

  • 7. From the guest editor: Triple-negative breast cancer.
    Hudis CA
    Cancer J; 2010; 16(1):10-1. PubMed ID: 20164684
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changing receptor status and treatment in breast cancer].
    Nomura Y
    Gan No Rinsho; 1983 May; 29(6):644-7. PubMed ID: 6876434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triple-negative breast cancer.
    Oncology (Williston Park); 2010 Oct; 24(10 Suppl):40a. PubMed ID: 21275325
    [No Abstract]   [Full Text] [Related]  

  • 10. [Estrogen receptors of the human breast].
    El'tsina NV
    Vopr Onkol; 1978; 24(8):108-15. PubMed ID: 358579
    [No Abstract]   [Full Text] [Related]  

  • 11. [How to optimize the clinical therapeutic protocol for triple-positive breast cancer].
    Wang N; Wang YJ
    Zhonghua Zhong Liu Za Zhi; 2010 Apr; 32(4):241-3. PubMed ID: 20510070
    [No Abstract]   [Full Text] [Related]  

  • 12. Estrogen receptors, antibodies and hormone dependent cancer.
    DeSombre ER; Greene GL; King WJ; Jensen EV
    Prog Clin Biol Res; 1984; 142():1-21. PubMed ID: 6538684
    [No Abstract]   [Full Text] [Related]  

  • 13. Solving the puzzle of hormone-dependent breast cancer.
    Santen RJ
    Trans Am Clin Climatol Assoc; 1992; 103():164-75. PubMed ID: 1413376
    [No Abstract]   [Full Text] [Related]  

  • 14. Hormone receptor status as an independent variable affecting the survival of advanced breast cancer patients with brain metastases.
    Harputluoglu H; Cengiz M; Altundag K
    Radiother Oncol; 2007 Mar; 82(3):356-7; author reply 357. PubMed ID: 17126939
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytoplasmic and nuclear estrogen and progesterone receptors in male breast cancer.
    Pegoraro RJ; Nirmul D; Joubert SM
    Cancer Res; 1982 Nov; 42(11):4812-4. PubMed ID: 7127316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple-negative breast cancer.
    Winkeljohn DL
    Clin J Oncol Nurs; 2008 Dec; 12(6):861-3. PubMed ID: 19064379
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular heterogeneity of cytosolic forms of estrogen receptors from human breast tumors.
    Kute TE; Heidemann P; Wittliff JL
    Cancer Res; 1978 Nov; 38(11 Pt 2):4307-13. PubMed ID: 698972
    [No Abstract]   [Full Text] [Related]  

  • 18. Predicting the future of breast cancer.
    Borg A; Fernö M; Peterson C
    Nat Med; 2003 Jan; 9(1):16-8. PubMed ID: 12514712
    [No Abstract]   [Full Text] [Related]  

  • 19. Pure and mixed hormone receptor positive breast tumors: are they different from therapeutic point of view?
    Altundag K; Altundag O; Gunduz E; Silay YS; Boruban C
    Med Hypotheses; 2005; 65(1):194. PubMed ID: 15893141
    [No Abstract]   [Full Text] [Related]  

  • 20. [Steroid receptors and breast carcinoma].
    Pasić R; Dulbegović B; Softić D; Wittlif JL
    Med Pregl; 1991; 44(1-2):48-51. PubMed ID: 1870463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.